
Academic Journal
Q3Infectious Disorders – Drug Targets
About Infectious Disorders – Drug Targets
Infectious Disorders - Drug Targets is a scholarly journal published by Bentham Science Publishers. SCImago 2025 lists it in Q3, with an SJR of 0.308 and H-index of 64.
Coverage: 2006-2025. Research categories: Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4).
Source-backed journal facts
Topics in published research
COVID-19 Clinical Research Studies; SARS-CoV-2 and COVID-19 Research; Antibiotic Resistance in Bacteria; Tuberculosis Research and Epidemiology; Diverse Scientific Research Studies; HIV/AIDS drug development and treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report.
SeyedAhmad SeyedAlinaghi
2021 · DOI: 10.2174/22123989mteyymjmt5Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review.
Timotius Ivan Hariyanto
2021 · DOI: 10.2174/22123989mtexzmde55In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Trinath Chowdhury
2021 · DOI: 10.2174/22123989mta4unteozPleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report
Zahra Ahmadinejad
2021 · DOI: 10.2174/22123989mta3cmjao5Chloroquine as Chemoprophylaxis for COVID-19: Will This Work.
Sherief Abd-Elsalam
2021 · DOI: 10.2174/22123989mta4jndc0wA Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
Suraj N. Mali
2021 · DOI: 10.2174/22123989mta29ntao3Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Nahid Akhtar
2021 · DOI: 10.2174/22123989mtewlmtif2SARS-CoV-2: The Path of Prevention and Control
Amal A. Mohamed
2021 · DOI: 10.2174/22123989mta2godae1The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy.
Bilha Baby
2021 · DOI: 10.2174/22123989mta5znze92Characteristics of HSV-2, M. genitalium and C. trachomatis in HPV Genotypes Associated with Cervical Intraepithelial Neoplasia and Genital Infections
Mona Moharreri
2021 · DOI: 10.2174/22123989mtazwmzuj2Transmission Modes of COVID-19: A Systematic Review.
Esmaeil Mehraeen
2021 · DOI: 10.2174/22123989mtexjnten0Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV/Aids: Ototoxicity Monitoring Protocol Recommendation
Katijah Khoza-Shangase
2020 · DOI: 10.2174/22123989otm3emdybtcvyA Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
Fereshteh Ghiasvand
2020 · DOI: 10.2174/22123989mta2cmjmoxA Review on Free Radicals and Antioxidants
Hourieh Alkadi
2020 · DOI: 10.2174/22123989oteznmziwtcvyRepurposing of Existing Drugs for the Bacterial Infections: An In silico and In vitro Study
Yachika Kapoor
2020 · DOI: 10.2174/22123989otq3xnjartcvyParasitic Infections of Wild Boars (Sus scrofa) in Iran: A Literature Review.
Bahman Maleki
2020 · DOI: 10.2174/22123989otk2qnzqptcvyOutcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection
Ossama A. Ahmed
2020 · DOI: 10.2174/22123989otuyrodyjtcvyClinical and Epidemiologic Features of Visceral Leishmaniasis in Children: A 6-year Study from an Iranian Referral Hospital
Mohamadreza Abdolsalehi
2020 · DOI: 10.2174/22123989otg3sodydtcvyHepatitis C Virus: Efficacy of New DAAs Regimens
Amal Ahmed Mohamed
2020 · DOI: 10.2174/22123989otu5bnjcvtcvyCounter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients
Cédric Annweiler
2020 · DOI: 10.2174/22123989mta2cnzilwReviews
Community Reviews
Version History
October 4, 2026 at 9:29 pm
October 2, 2026